Fate Therapeutics Inc (FATE): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5,744 US Dollar | 4 | 1 | 6 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 119.820.514 | 10,01 | 6,6 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Fate Therapeutics Inc
Mitarbeiter 161
Handelsplatz NASDAQ
Ticker Symbol FATE
IPO Datum 2013-10-01
Adresse 12278 Scripps Summit Drive, San Diego, CA, United States, 92131
Webseite https://www.fatetherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Bahram Valamehr M.B.A., Ph.D. | President, CEO & Director |
| 2 | Mr. Kamal Adawi M.S., MBA | CFO & Treasurer |
| 3 | Ms. Cindy R. Tahl J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
| 4 | Ms. Jessica Francis | Senior Vice President of Human Resources & Operations |
| 5 | Dr. Martin Hosking | Head of Research |
| 6 | Dr. Tunde Babalola Ph.D. | Senior Vice President of Technical Operations & Quality |
| 7 | Mr. Ryan Douglas | Senior Director of Investor Relations & Business Development |
| 8 | Mr. Andrew Henry | Senior Vice President of Clinical Operations |
| 9 | Dr. Yu Cai J.D., Ph.D. | Head of Intellectual Property & Assistant General Counsel |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Redmile Group, LLC | 10,74% | 27,93 Mio. USD |
| 2 | BlackRock Inc | 6,09% | 15,84 Mio. USD |
| 3 | Vanguard Portfolio Management, LLC | 3,79% | 9,87 Mio. USD |
| 4 | Vanguard Capital Management, LLC | 3,71% | 9,65 Mio. USD |
| 5 | Acadian Asset Management LLC | 3,63% | 9,44 Mio. USD |
| 6 | AQR Capital Management LLC | 3,20% | 8,33 Mio. USD |
| 7 | Two Sigma Investments LLC | 3,00% | 7,79 Mio. USD |
| 8 | Johnson & Johnson | 2,82% | 7,33 Mio. USD |
| 9 | Renaissance Technologies Corp | 2,49% | 6,47 Mio. USD |
| 10 | Millennium Management LLC | 2,03% | 5,28 Mio. USD |
| 11 | The Goldman Sachs Group Inc | 1,71% | 4,45 Mio. USD |
| 12 | Geode Capital Management, LLC | 1,10% | 2,87 Mio. USD |
| 13 | T. Rowe Price Investment Management,Inc. | 0,90% | 2,34 Mio. USD |
| 14 | Jane Street Group LLC | 0,86% | 2,23 Mio. USD |
| 15 | Citadel Advisors Llc | 0,83% | 2,16 Mio. USD |
| 16 | Bruce & Co Inc | 0,83% | 2,15 Mio. USD |
| 17 | Morgan Stanley - Brokerage Accounts | 0,58% | 1,51 Mio. USD |
| 18 | Vanguard Fiduciary Trust Co | 0,53% | 1,39 Mio. USD |
| 19 | Charles Schwab Investment Management Inc | 0,51% | 1,33 Mio. USD |
| 20 | UBS Group AG | 0,49% | 1,28 Mio. USD |